“This survey gives the cardiology community clearer insights into how to enhance the conversations we are already having and align on patient priorities," one specialist said. 

“This is a procedure that’s done once, and it keeps giving a benefit over time,” one researcher said. “This is going to prevent thousands of strokes.”

Percutaneous edge-to-edge mitral valve repair was associated with improved outcomes among TAVR patients with persistent mitral regurgitation. 

After one year, the stroke rate for LAAO patients was just 1.53%. 

According to the real-world analysis, treatment with TriClip was associated with no major adverse events and a procedural success rate of 100%. 

Low levels of residual mitral regurgitation after TEER can make a big impact on patient outcomes, researchers explained in a new analysis. 

Researchers emphasized the importance of these findings, noting that hypertension can lead to significant cardiovascular complications.

The team's findings were presented at the 101st Annual Meeting of the American Association for Thoracic Surgery and published in the Journal of the American College of Cardiology.

Overall, one-year findings showed that there were no instances of mortality, endocarditis, major stent fractures or surgical intervention among patients who received the Harmony TPV.